Illinois plaintiff files Risperdal pharmaceutical mass tort claim in Pa. court
An Illinois man is suing the makers of the anti-psychotic drug Risperdal, claiming his ingestion of the pharmaceutical for a 10-year period caused him to sustain bodily injuries and financial hardship. Steve D. Shadowen, an attorney with the Mechanicsburg, Pa. firm of Hilliard & Shadowen, filed the mass tort claim Aug. 8 at the Philadelphia Court of Common Pleas on behalf of Raymond McAfee. The suit was filed as a short-form complaint in the master Risperdal litigation in state court. The lawsuit claims that McAfee, who resides in Olympia Fields, Illinois, took Risperdal from about 2002 through this year, and as a result of his taking the drug he developed Gynecomastia, or a condition that causes enlarged breast tissues in males. McAfee also allegedly developed diabetes mellitus and involuntary movement disorders as a result of his ingesting the pharmaceutical, the complaint states. The defendants named in the lawsuit are Ortho-McNeil-Janssen Pharmaceuticals, Johnson & Johnson Co., Excerpta Medica Inc. and Elsevier Inc. The complaint contains counts of negligence, fraud, strict product liability, breach of express and implied warranties, unfair and deceptive trade practices, conspiracy, and violations of Pennsylvania’s Unfair Trade Practices and Consumer Protection Law. The plaintiff seeks unspecified compensatory and punitive damages. A jury trial has been demanded. Risperdal mass tort cases were consolidated at Philadelphia’s Common Pleas Court back in the fall of 2010. They are being overseen by Judge Sandra Mazer Moss. The case ID number is 120800540.